Design, synthesis and biological evaluation of indane derived GPR40 agoPAMs

Bioorg Med Chem Lett. 2019 Jul 15;29(14):1842-1848. doi: 10.1016/j.bmcl.2019.04.050. Epub 2019 May 2.

Abstract

GPR40 (FFAR1 or FFA1) is a G protein-coupled receptor, primarily expressed in pancreatic islet β-cells and intestinal enteroendocrine cells. When activated by fatty acids, GPR40 elicits increased insulin secretion from islet β-cells only in the presence of elevated glucose levels. Towards this end, studies were undertaken towards discovering a novel GPR40 Agonist whose mode of action is via Positive Allosteric Modulation of the GPR40 receptor (AgoPAM). Efforts were made to identify a suitable GPR40 AgoPAM tool molecule to investigate mechanism of action and de-risk liver toxicity of GPR40 AgoPAMs due to reactive acyl-glucuronide (AG) metabolites.

Keywords: Diabetes; FFA1; GPCR; GPR40 AgoPAM; Indane.

MeSH terms

  • Drug Design
  • Humans
  • Indans / metabolism*
  • Receptors, G-Protein-Coupled / agonists*

Substances

  • Indans
  • Receptors, G-Protein-Coupled
  • indan